news 14 Nov 2012

RABEPRAZOLE LAUNCH

It is never a dull moment for the Medis launch team, now just 2 weeks after the launch of Riluzole, Medis is successfully launching Rabeprazole with five customers in the following markets: Italy, Spain & France at the day of patent expiry.

Rabeprazole is the generic equivalent of Janssens´s brand Pariet® (brand name used in Europe, Brazil, Canada, Japan, Russia & Australia). Rabeprazole is an antiulcer drug in the class of proton pump inhibitors used to treat duodenal ulcers and erosive or ulcerative gastro esophageal reflux disease (GERD). ​

Locations

worldwide operations and facilities

ACBF5E14-A57C-4383-BDFF-04EA66B1D3D8 Created with sketchtool.